Background: A significant number of developing countries have no facilities to produce medical radioisotopes and radiopharmaceuticals.
Objective: In this paper we show that access to life-saving radioisotopes and radiopharmaceuticals and the geographical distribution of corresponding infrastructure is highly unbalanced worldwide.
Methods: We discuss the main issues which need to be addressed in order to establish the production of radioisotopes and radiopharmaceuticals, which are especially important for developing countries as newcomers in the field.
The sensitivity calculation of airborne gamma-ray spectrometer (AGS) is usually performed by on-ground or in-flight calibration. However, both methods are cost-ineffective or not permissive, especially for artificial radioisotopes with short half-lives. Alternative to these methods is the Monte Carlo simulation, which has been widely applied over the last few decades.
View Article and Find Full Text PDF